Digital Pathology: Technologies and Global Markets
The global digital pathology market totaled nearly $2.1 billion in 2012. This market is expected to grow at a compound annual growth rate (CAGR) of 14.7% from $2.2 billion in 2013 to nearly $4.5 billion in 2018.
This report provides:
An overview of the global digital pathology market.
Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
Information on key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence, and geographic trends.
Discussion on various supply chain members such as manufacturers, suppliers, service providers and diagnostic centres.
STUDY AND OBJECTIVE
Objectives of this study report include:
To define and identify the structure for the global digital pathology market and discuss key market issues.
To measure and estimate the global digital pathology market and its segments for products, end users and key applications for the period from 2013 to 2018.
To identify opportunities and major factors driving and inhibiting growth of the global labware market and its subsegments.
To identify and analyze key market issues, trends, gaps and opportunities in each of the micro-markets.
To intensively study the key factors that impact market growth by subsegments and geography and to analyze trends and opportunities in major regions, including North America, Europe, Asia and the rest of the world (ROW).
To identify key companies, product portfolios, strategies and recent developments.
To assess key competitive scenarios, top strategies and segments of key companies.
To present key conclusions conducted through intensive primary and secondary research.
The role of a conventional laboratory is to focus on cost savings, increased laboratory workload and innovative technologies, such as m-health. Digital pathology and telepathology are seen as effective solutions with significant scopes to address the prevailing issues of cost, time and technology. Digital pathology and telepathology offer improved connectivity and reduce healthcare costs. Successful and consistent adoption of digital pathology and telepathology in developed economies is encouraging the developing economies to experiment as well.
The creation of disciplined regulatory environments that protect patient safety and focus on electronic medical records (EMRs), the need for quick diagnoses and the maintenance of cost issues will drive the market. The evolving market, however, presents significant challenges, including significant deployment costs, U.S. Food and Drug Administration (FDA) approvals, technological complexities, and a lack of skilled staff and conventional pathologists.
The scenario is very different in developing economies, where the concepts of telepathology and digital pathology are so far relevant only to niche and reputed laboratories. There are significant complexities involved in the process of enabling the adoption of novel technologies. Technology providers are having difficulty meeting varied customer expectations in different regions with respect to the products or services they offer, price and quality. This requires a deeper understanding of the existing infrastructure and process, cost-versus-value expectations, regulatory issues and other driving forces. This report addresses these issues and provides a comprehensive and objective study to enhance the market presence of participants such as digital pathology technology providers, product manufacturers, service providers, system integrators and other key value chain members.
SCOPE OF THE REPORT
This report includes forecasted trends and sales in the digital pathology and telepathology markets through 2018. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed. There is a detailed discussion on market dynamics and the level of impact, key geographies and respective trends and competitive scenarios that will form the base data for qualitative analysis and market estimates.
The digital pathology and telepathology market has been analyzed for the four main geographic regions: North America, Europe, Asia and the rest of the world (ROW).
aThe report will provide details with respect to the conventional process of pathology laboratories, but it will specifically exclude the scope of market analysis for conventional path-lab devices (e.g., conventional microscopes, slides). The connectivity and network issues discussed in the report will be specific to data and information generated from pathology labs and that regarding specific diagnosis, but it will exclude general hospital-based m-health issues. Telepathology covered in the report is limited to diagnostic, research and development (R&D), and education and training applications. It excludes the scope of telemedicine at a larger level.